oxonic acid has been researched along with Cancer of Colon in 79 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to determine the maximum tolerated dose, recommended dose and dose-limiting toxicities of irinotecan (CPT-11) plus S-1 in advanced colorectal cancer." | 9.14 | A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Tsuchida, K, 2009) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 5.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "The aim of this study was to determine the maximum tolerated dose, recommended dose and dose-limiting toxicities of irinotecan (CPT-11) plus S-1 in advanced colorectal cancer." | 5.14 | A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Tsuchida, K, 2009) |
| "Patients aged 20-80 with stage II/III rectal cancer undergoing curative surgery without preoperative therapy were randomly assigned to receive UFT (500-600 mg/day on days 1-5, followed by 2 days rest) or S-1 (80-120 mg/day on days 1-28, followed by 14 days rest) for 1 year." | 2.82 | A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC). ( Baba, H; Emi, Y; Hamada, C; Ikejiri, K; Kakeji, Y; Kotake, M; Maeda, K; Maehara, Y; Matsuda, C; Matsuda, H; Munemoto, Y; Murata, A; Oki, E; Saji, S; Sasaki, K; Suenaga, T; Yoshida, K, 2016) |
| " In both arms, S-1 dosing (oral) will be based on body surface area (80 mg/day for body surface area<1." | 2.80 | Randomized phase II study of S-1 dosing schedule for resected colorectal cancer. ( Doki, Y; Hasegawa, J; Hata, T; Ikeda, M; Ikenaga, M; Kato, T; Matsuda, C; Mizushima, T; Mori, M; Murata, K; Nakata, K; Nezu, R; Nishimura, J; Ohue, M; Satoh, T; Sekimoto, M; Shingai, T; Takemasa, I; Uemura, M; Yamamoto, H, 2015) |
| " The overall incidence of adverse events (AEs) were 80% in S-1 and 74% in UFT/LV." | 2.77 | Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial. ( Boku, N; Endo, T; Ikejiri, K; Kameoka, S; Kinugasa, Y; Kotake, K; Matsubara, Y; Mochizuki, H; Mochizuki, I; Nakamoto, Y; Shinozaki, H; Sugihara, K; Takagane, A; Takahashi, K; Takahashi, Y; Takii, Y; Takiuchi, H; Tomita, N; Watanabe, M; Watanabe, T, 2012) |
| " Major adverse effects were hematological toxicities, gastrointestinal disturbance, neurosensory toxicity." | 2.76 | [Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer]. ( Jin, ZM; Zhu, QC, 2011) |
| "After the operation, he developed disseminated intravascular coagulation(DIC)and severe anemia." | 2.50 | [A case of disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation caused by advanced colon cancer successfully treated with SOX/bevacizumab]. ( Endo, Y; Inoue, M; Kakimoto, Y; Kato, Y; Kimura, T; Matsuda, Y; Matsuoka, N; Murakami, O; Sasakabe, H; Suzuki, H; Toyoda, A; Ushimaru, Y, 2014) |
| " During long-term administration of S-1, some mice had loose stools and an increase in apoptotic bodies was observed in the ileal crypts." | 1.46 | Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration. ( Suga, Y; Takehana, K, 2017) |
| "The mean recurrence-free survival was 13." | 1.43 | [Adjuvant Systemic Chemotherapy with S-1/Oxaliplatin or mFOLFOX6 after Curative Resection of Distant Metastases in Patients with Colorectal Cancer]. ( Amada, E; Baba, S; Kameyama, N; Mitsuhashi, H; Miyata, R; Tomita, M, 2016) |
| "Metastatic recurrence occurred on the transverse colon, for which she underwent transverse colectomy 2." | 1.42 | [A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy]. ( Fujii, Y; Fujita, H; Fujita, J; Funaki, H; Kaida, D; Kinami, S; Kosaka, T; Miura, S; Morioka, E; Nakano, Y; Noguchi, M; Ohonishi, T; Ohono, Y; Sakata, N; Tomita, Y; Ueda, N, 2015) |
| "A 55-year-old man suffering from gastric cancer associated with metastases to the lymph node, gallbladder, and liver was administered chemotherapy with S-1 and cisplatin." | 1.40 | [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. ( Akiyama, Y; Hasuike, Y; Higuchi, I; Miyamoto, M; Tanigawa, T; Yamamoto, M, 2014) |
| "She was diagnosed as colon cancer with hepatic metastasis." | 1.39 | [A case of metastatic colon cancer effectively treated by XELOX and IRIS]. ( Fujiyama, Y; Kaneko, H; Kikuchi, M; Kinoshita, S; Nishizawa, T; Sakuno, T; Suzuki, H; Takahashi, M, 2013) |
| "We recently proposed an S-1 combined with oxaliplatin (SOXL) regimen, a combination treatment consisting of oral metronomic S-1 dosing and intravenous administration of oxaliplatin (l-OHP) containing PEGylated liposomes, which showed potent antitumor activity in vivo." | 1.39 | Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical application. ( Abu Lila, AS; Ishida, T; Kiwada, H; Nagao, A, 2013) |
| " When chemotherapy with S-1 or UFT/LV started from the micrometastasis stage, not the advanced macroscopic metastasis stage, anti-LNM efficacy of S-1 was significantly higher than that of UFT/LV at the dosage in which antitumor activity of the two drugs against primary subcutaneous tumor was comparable." | 1.36 | Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. ( Hirai, T; Ito, Y; Kato, T; Kodera, Y; Nakanishi, H; Nakao, A, 2010) |
| " We treated the patient with S-1 combined with CPT-11." | 1.35 | [Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11]. ( Ishii, Y; Mado, K; Manmoto, J; Masuda, H; Mazaki, T; Okame, H; Suzuki, K; Takayama, T, 2008) |
| "Goblet cell carcinoid of the appendix is a rare neoplasm and clinically tends to take a malignant course." | 1.35 | [A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy]. ( Fujimoto, H; Harada, E; Horiuchi, N; Iwasaka, N; Kashima, M; Kimura, S; Masuda, K; Matsushita, T; Nakamura, S; Oshima, Y; Shichijo, K; Shinomiya, S; Takeichi, T; Tamaki, Y; Yoshida, S, 2008) |
| "A 45-year-old male patient with right colonic cancer, of which clinical finding was SIM1 (No." | 1.35 | [A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy]. ( Inoue, S; Nasu, K; Noda, K; Umekita, N, 2009) |
| "An 82-year-old female with unresectable colon cancer accompanied by multiple lung metastasis was treated with S-1." | 1.35 | [An elderly case of recurrent colon cancer responding to weekly S-1 chemotherapy leading to partial response]. ( Arita, A; Fujimoto, M; Mochizuki, K; Sakai, Y, 2008) |
| "By a diagnosis of descending colon cancer, descending colon ablative operation and D1 lymph node dissection were performed on April 22, 2004." | 1.33 | [A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy]. ( Fujishima, M; Fukunaga, M; Furukawa, H; Imamura, H; Kawasaki, T; Kishimoto, T; Kondo, M; Masutani, S; Nakayama, T; Ooshiro, R; Takemoto, H; Tanaka, J; Tatsuta, M; Yamamoto, K, 2005) |
| "The patient, who had unresectable colon cancer metastases to the liver and lung, was referred to us for chemotherapy from an affiliated hospital; he had no cardiac history." | 1.33 | 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine. ( Hatakeyama, K; Muneoka, K; Shirai, Y; Wakai, T; Yokoyama, N, 2005) |
| "Gastrointestinal endoscopy showed esophageal cancer invading the gastric fundus." | 1.32 | Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin. ( Doi, R; Indo, T; Iwase, H; Kaida, S; Kato, E; Nakarai, K; Okeya, M; Shimada, M; Tsuzuki, T, 2004) |
| "The therapeutic effect of S-1 on human colon cancer xenografts (TK-13) with high metastatic potential to the liver was evaluated." | 1.30 | Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma. ( Baba, M; Kamiya, K; Kanai, T; Konno, H; Matsumoto, K; Nakamura, S; Tanaka, T, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (5.06) | 18.2507 |
| 2000's | 30 (37.97) | 29.6817 |
| 2010's | 43 (54.43) | 24.3611 |
| 2020's | 2 (2.53) | 2.80 |
| Authors | Studies |
|---|---|
| Ando, K | 1 |
| Emi, Y | 2 |
| Miyanari, N | 1 |
| Tsuji, A | 2 |
| Sakai, K | 1 |
| Sawai, T | 1 |
| Imamura, H | 2 |
| Mori, S | 1 |
| Tokunaga, S | 1 |
| Oki, E | 2 |
| Saeki, H | 1 |
| Kakeji, Y | 2 |
| Akagi, Y | 1 |
| Baba, H | 3 |
| Maehara, Y | 4 |
| Mori, M | 5 |
| Saito, Y | 1 |
| Takekuma, Y | 1 |
| Komatsu, Y | 2 |
| Sugawara, M | 1 |
| Matsuda, K | 1 |
| Namiki, T | 1 |
| Ueno, M | 1 |
| Hashimoto, T | 2 |
| Hanafusa, T | 1 |
| Yokozeki, H | 1 |
| Suga, Y | 1 |
| Takehana, K | 1 |
| Kabashima, A | 1 |
| Kimura, K | 1 |
| Sanefuji, K | 1 |
| Maekawa, S | 1 |
| Baba, T | 1 |
| Kokuryo, T | 1 |
| Yamaguchi, J | 1 |
| Yokoyama, Y | 1 |
| Uehara, K | 2 |
| Ebata, T | 1 |
| Nagino, M | 2 |
| Tago, T | 1 |
| Suzuki, K | 2 |
| Nishida, K | 1 |
| Maruyama, T | 1 |
| Shimazaki, J | 1 |
| Shimoda, M | 1 |
| Suzuki, S | 3 |
| Kou, K | 1 |
| Morishita, Y | 1 |
| Nobori, C | 1 |
| Uchima, Y | 1 |
| Aomatsu, N | 1 |
| Okada, T | 1 |
| Miyamoto, H | 1 |
| Kurihara, S | 1 |
| Wang, E | 1 |
| Hirakawa, T | 1 |
| Iwauchi, T | 1 |
| Morimoto, J | 1 |
| Yamagata, S | 1 |
| Nakazawa, K | 1 |
| Takeuchi, K | 1 |
| Benson, AB | 1 |
| Nishizawa, T | 1 |
| Kinoshita, S | 1 |
| Sakuno, T | 1 |
| Fujiyama, Y | 1 |
| Kikuchi, M | 1 |
| Kaneko, H | 1 |
| Suzuki, H | 2 |
| Takahashi, M | 1 |
| Yoh, T | 1 |
| Wada, S | 1 |
| Kobayashi, A | 1 |
| Nakamura, Y | 1 |
| Kato, T | 3 |
| Nakayama, H | 1 |
| Okamura, R | 1 |
| Mizushima, T | 3 |
| Ide, Y | 1 |
| Murata, K | 3 |
| Ohashi, I | 1 |
| Yasumasa, K | 1 |
| Fukunaga, M | 2 |
| Takemoto, H | 2 |
| Tamagawa, H | 1 |
| Hasegawa, J | 2 |
| Hata, T | 3 |
| Takemasa, I | 3 |
| Ikeda, M | 2 |
| Yamamoto, H | 3 |
| Sekimoto, M | 2 |
| Nezu, R | 3 |
| Doki, Y | 3 |
| Zhang, E | 1 |
| Cao, W | 1 |
| Cheng, C | 1 |
| Huo, BL | 1 |
| Wang, YH | 1 |
| Yoshida, M | 2 |
| Ishiguro, M | 2 |
| Ikejiri, K | 3 |
| Mochizuki, I | 2 |
| Nakamoto, Y | 2 |
| Kinugasa, Y | 2 |
| Takagane, A | 2 |
| Endo, T | 2 |
| Shinozaki, H | 2 |
| Takii, Y | 2 |
| Mochizuki, H | 2 |
| Kotake, K | 2 |
| Kameoka, S | 3 |
| Takahashi, K | 3 |
| Watanabe, T | 2 |
| Watanabe, M | 4 |
| Boku, N | 2 |
| Tomita, N | 2 |
| Nakatani, E | 1 |
| Sugihara, K | 3 |
| Matsuoka, N | 1 |
| Ushimaru, Y | 1 |
| Kakimoto, Y | 1 |
| Toyoda, A | 1 |
| Endo, Y | 1 |
| Murakami, O | 1 |
| Kato, Y | 1 |
| Inoue, M | 1 |
| Kimura, T | 1 |
| Matsuda, Y | 1 |
| Sasakabe, H | 1 |
| Cheng, AL | 1 |
| Li, J | 1 |
| Vaid, AK | 1 |
| Ma, BB | 1 |
| Teh, C | 1 |
| Ahn, JB | 1 |
| Bello, M | 1 |
| Charoentum, C | 1 |
| Chen, LT | 1 |
| de Lima Lopes, G | 1 |
| Ho, GF | 1 |
| Kong, HL | 1 |
| Lam, KO | 1 |
| Liu, TS | 1 |
| Park, YS | 1 |
| Sriuranpong, V | 1 |
| Sudoyo, AW | 1 |
| Wang, JY | 1 |
| Zhang, J | 1 |
| Zhang, SZ | 1 |
| Ciardiello, F | 1 |
| Köhne, CH | 1 |
| Shaw, M | 1 |
| Kim, TW | 1 |
| Abali, H | 1 |
| Yavuz, S | 1 |
| Calıkusu, Z | 1 |
| Seyrek, E | 1 |
| Sueda, T | 1 |
| Kudo, T | 1 |
| Sakai, D | 1 |
| Uemura, M | 2 |
| Nishimura, J | 2 |
| Ezoe, S | 1 |
| Matsumoto, K | 2 |
| Satoh, T | 2 |
| Konishi, K | 1 |
| Okuyama, M | 1 |
| Hiraoka, K | 1 |
| Nakagawa, T | 1 |
| Kim, C | 1 |
| Endo, S | 1 |
| Yamada, T | 1 |
| Nishijima, J | 1 |
| Okada, K | 3 |
| Oka, Y | 1 |
| Uemura, H | 1 |
| Omura, Y | 1 |
| Miyake, Y | 1 |
| Nakane, S | 1 |
| Higaki, N | 1 |
| Hayashida, H | 1 |
| Higuchi, I | 1 |
| Akiyama, Y | 1 |
| Yamamoto, M | 2 |
| Tanigawa, T | 1 |
| Hasuike, Y | 1 |
| Miyamoto, M | 2 |
| Matsuda, C | 2 |
| Nakata, K | 1 |
| Shingai, T | 1 |
| Ikenaga, M | 1 |
| Ohue, M | 1 |
| Hijikawa, T | 1 |
| Yoshida, R | 1 |
| Yamada, M | 1 |
| Nakatani, K | 1 |
| Tokuhara, K | 1 |
| Kitade, H | 1 |
| Shikata, N | 1 |
| Yoshioka, K | 1 |
| Kon, M | 1 |
| Tomita, Y | 1 |
| Fujii, Y | 1 |
| Miura, S | 1 |
| Fujita, J | 1 |
| Morioka, E | 1 |
| Kaida, D | 1 |
| Ohonishi, T | 1 |
| Ohono, Y | 1 |
| Noguchi, M | 1 |
| Funaki, H | 1 |
| Fujita, H | 1 |
| Kinami, S | 1 |
| Nakano, Y | 2 |
| Ueda, N | 1 |
| Kosaka, T | 1 |
| Sakata, N | 1 |
| Murata, A | 1 |
| Yoshida, K | 1 |
| Maeda, K | 1 |
| Munemoto, Y | 1 |
| Sasaki, K | 1 |
| Kotake, M | 1 |
| Suenaga, T | 1 |
| Matsuda, H | 1 |
| Hamada, C | 1 |
| Saji, S | 1 |
| Miyata, R | 1 |
| Kameyama, N | 1 |
| Tomita, M | 1 |
| Mitsuhashi, H | 1 |
| Baba, S | 1 |
| Amada, E | 1 |
| Kamata, A | 1 |
| Kano, T | 1 |
| Hagiwara, H | 1 |
| Sarukawa, H | 1 |
| Wada, Y | 2 |
| Miyamae, T | 1 |
| Koizumi, M | 1 |
| Abe, Y | 1 |
| Natori, J | 1 |
| Uchiyama, K | 1 |
| Nagase, S | 1 |
| Iyoda, T | 1 |
| Kanno, H | 1 |
| Akase, T | 1 |
| Arakawa, I | 1 |
| Inoue, T | 1 |
| Uetsuka, Y | 1 |
| Aoki, Y | 1 |
| Kojima, S | 1 |
| Kataoka, T | 1 |
| Nagao, S | 1 |
| Kayukawa, S | 1 |
| Mori, F | 1 |
| Masaki, A | 1 |
| Yamada, K | 1 |
| Kawai, M | 2 |
| Kabeya, M | 1 |
| Hibi, S | 1 |
| Furuta, R | 1 |
| Ina, K | 1 |
| Mazaki, T | 1 |
| Mado, K | 1 |
| Manmoto, J | 1 |
| Okame, H | 1 |
| Ishii, Y | 1 |
| Masuda, H | 1 |
| Takayama, T | 1 |
| Shiozawa, M | 1 |
| Sugano, N | 1 |
| Tsuchida, K | 1 |
| Morinaga, S | 1 |
| Akaike, M | 1 |
| Sugimasa, Y | 1 |
| Nakamura, S | 2 |
| Kimura, S | 1 |
| Kashima, M | 1 |
| Shichijo, K | 1 |
| Yoshida, S | 1 |
| Harada, E | 1 |
| Matsushita, T | 1 |
| Oshima, Y | 1 |
| Tamaki, Y | 1 |
| Horiuchi, N | 1 |
| Takeichi, T | 1 |
| Fujimoto, H | 1 |
| Masuda, K | 1 |
| Iwasaka, N | 1 |
| Shinomiya, S | 1 |
| Yokoyama, T | 2 |
| Tokuhara, H | 1 |
| Egawa, T | 1 |
| Hashimoto, O | 1 |
| Seki, H | 1 |
| Koyanagi, K | 1 |
| Bessho, T | 1 |
| Saito, H | 2 |
| Watanuki, A | 1 |
| Tabira, Y | 1 |
| Ikeda, N | 1 |
| Urakawa, M | 1 |
| Sakano, T | 1 |
| Noda, K | 1 |
| Umekita, N | 1 |
| Nasu, K | 1 |
| Inoue, S | 1 |
| Miyahira, T | 1 |
| Teruya, N | 1 |
| Matsuura, F | 1 |
| Murayama, S | 1 |
| Aka, H | 1 |
| Teruya, J | 1 |
| Hanashiro, N | 1 |
| Nishihara, M | 1 |
| Okushima, N | 1 |
| Toda, Y | 1 |
| Kiyuna, M | 1 |
| Oka, T | 2 |
| Tokumo, M | 1 |
| Yamakawa, T | 1 |
| Onoda, Y | 1 |
| Suzuka, I | 1 |
| Shiota, K | 1 |
| Ito, Y | 1 |
| Nakanishi, H | 1 |
| Kodera, Y | 1 |
| Hirai, T | 1 |
| Nakao, A | 1 |
| Fukushima, M | 4 |
| Sakamoto, K | 1 |
| Ohshimo, H | 1 |
| Nakagawa, F | 1 |
| Taguchi, T | 2 |
| Sadahiro, S | 1 |
| Suzuki, T | 2 |
| Maeda, Y | 1 |
| Tanaka, A | 1 |
| Kanoda, H | 1 |
| Kamijo, A | 1 |
| Sunaga, T | 1 |
| Harada, N | 1 |
| Hayashi, T | 1 |
| Suzuki, M | 1 |
| Sasaki, Y | 1 |
| Kunieda, K | 1 |
| Imai, T | 2 |
| Sakuratani, T | 1 |
| Tajima, JY | 1 |
| Kanematsu, M | 1 |
| Yamada, A | 1 |
| Matsuhashi, N | 1 |
| Tanaka, C | 1 |
| Nishina, T | 1 |
| Nagao, N | 1 |
| Furuichi, N | 1 |
| Yanagawa, S | 1 |
| Kuga, Y | 1 |
| Tanaka, T | 2 |
| Okanobu, H | 1 |
| Arita, M | 1 |
| Yoshimi, S | 1 |
| Miwata, T | 1 |
| Fujino, H | 1 |
| Moriya, T | 2 |
| Ohya, T | 1 |
| Zhu, QC | 1 |
| Jin, ZM | 1 |
| Oono, R | 1 |
| Enomoto, N | 1 |
| Hosoya, N | 1 |
| Ueda, Y | 1 |
| Otsuki, S | 1 |
| Motoyama, K | 1 |
| Narita, T | 1 |
| Seshimo, A | 1 |
| Itabashi, M | 1 |
| Aratake, K | 1 |
| Ogawa, S | 1 |
| Hirosawa, T | 1 |
| Amano, K | 1 |
| Hirajima, S | 1 |
| Komatsu, S | 1 |
| Adachi, T | 1 |
| Sakuyama, A | 1 |
| Habuchi, Y | 1 |
| Otsuj, E | 1 |
| Sasaki, T | 1 |
| Miyashita, H | 1 |
| Miyanaga, T | 1 |
| Yamamoto, K | 2 |
| Sugiyama, K | 1 |
| Takiuchi, H | 1 |
| Takahashi, Y | 1 |
| Matsubara, Y | 1 |
| Nagao, A | 1 |
| Abu Lila, AS | 1 |
| Ishida, T | 1 |
| Kiwada, H | 1 |
| Okamura, S | 1 |
| Kato, R | 1 |
| Makino, S | 1 |
| Ohwada, Y | 1 |
| Nishigaki, T | 1 |
| Murakami, M | 1 |
| Yanagisawa, T | 1 |
| Ebisui, C | 1 |
| Yokouchi, H | 1 |
| Kinuta, M | 1 |
| Yoshimura, K | 2 |
| Tojima, Y | 1 |
| Kawai, S | 1 |
| Mokuno, Y | 1 |
| Maeda, A | 1 |
| Kyokane, T | 1 |
| Kobayashi, S | 2 |
| Yoshioka, Y | 1 |
| Sawabu, N | 1 |
| Taguchi, S | 1 |
| Osugi, H | 1 |
| Takemura, M | 1 |
| Lee, S | 1 |
| Kaneko, M | 1 |
| Tanaka, Y | 1 |
| Fujiwara, Y | 1 |
| Nishizawa, S | 1 |
| Iwasaki, H | 1 |
| Iwase, H | 1 |
| Indo, T | 1 |
| Shimada, M | 1 |
| Tsuzuki, T | 1 |
| Nakarai, K | 1 |
| Kaida, S | 1 |
| Doi, R | 1 |
| Okeya, M | 1 |
| Kato, E | 1 |
| Hiraki, M | 1 |
| Yakushiji, H | 1 |
| Hashiguchi, K | 1 |
| Harada, S | 1 |
| Waseda, R | 1 |
| Tatsuzawa, Y | 1 |
| Ohtake, Y | 1 |
| Kawaura, Y | 1 |
| Ooshiro, R | 1 |
| Fujishima, M | 1 |
| Tanaka, J | 1 |
| Kondo, M | 1 |
| Kishimoto, T | 1 |
| Nakayama, T | 1 |
| Masutani, S | 1 |
| Tatsuta, M | 1 |
| Kawasaki, T | 1 |
| Furukawa, H | 1 |
| Muneoka, K | 1 |
| Shirai, Y | 1 |
| Yokoyama, N | 1 |
| Wakai, T | 1 |
| Hatakeyama, K | 1 |
| Ohnuma, M | 1 |
| Uchiyama, T | 1 |
| Abe, T | 1 |
| Nakagawa, K | 1 |
| Kamiyama, Y | 1 |
| Ise, H | 1 |
| Ishizuka, T | 1 |
| Yoshiyasu, M | 1 |
| Yanagi, K | 1 |
| Bando, K | 1 |
| Tajiri, T | 2 |
| Mouri, T | 1 |
| Ogawa, M | 1 |
| Mitsuyama, Y | 1 |
| Yamagata, T | 1 |
| Kosuge, M | 1 |
| Ushigome, T | 1 |
| Eto, K | 1 |
| Anazawa, S | 1 |
| Yanaga, K | 1 |
| Matsutani, T | 1 |
| Egami, K | 1 |
| Sasajima, K | 1 |
| Maruyama, H | 1 |
| Oguro, A | 1 |
| Nanri, M | 1 |
| Miyamoto, Y | 1 |
| Ujiie, K | 1 |
| Iitaka, D | 1 |
| Koh, T | 1 |
| Yamazaki, J | 1 |
| Ohnishi, T | 1 |
| Kanoh, T | 1 |
| Kimura, Y | 1 |
| Iwazawa, T | 1 |
| Tono, T | 1 |
| Yano, K | 1 |
| Monden, T | 1 |
| Koga, M | 1 |
| Kamitani, T | 1 |
| Futami, K | 1 |
| Arima, S | 1 |
| Arita, A | 1 |
| Sakai, Y | 1 |
| Fujimoto, M | 1 |
| Mochizuki, K | 1 |
| Taira, M | 1 |
| Ito, T | 1 |
| Ganno, H | 1 |
| Ohbu, M | 1 |
| Ami, K | 1 |
| Nagahama, T | 1 |
| Tei, S | 1 |
| Ando, M | 1 |
| Kato, H | 1 |
| Matsuda, T | 1 |
| Shikata, S | 1 |
| Inagaki, D | 1 |
| Katayama, K | 1 |
| Shiraishi, R | 1 |
| Tanabe, H | 1 |
| Tani, K | 1 |
| Oosawa, H | 1 |
| Wada, H | 1 |
| Yasuda, S | 1 |
| Ooyama, A | 1 |
| Zhao, HY | 1 |
| Akiyama, S | 1 |
| Mimori, K | 1 |
| Sugimachi, K | 2 |
| Shirasaka, T | 3 |
| Nakano, K | 1 |
| Takechi, T | 1 |
| Satake, H | 1 |
| Uchida, J | 1 |
| Fujioka, A | 1 |
| Okabe, H | 1 |
| Oyama, K | 1 |
| Takeda, S | 1 |
| Unemi, N | 1 |
| Kurihara, M | 1 |
| Konno, H | 1 |
| Baba, M | 1 |
| Kanai, T | 1 |
| Kamiya, K | 1 |
| Kitamura, M | 1 |
| Arai, K | 1 |
| Iwasaki, Y | 1 |
| Takahashi, T | 1 |
| Saitoh, K | 1 |
| Fujii, T | 1 |
| Yamamitsu, S | 1 |
| Terashima, M | 1 |
| Hirata, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Phase III Study of UFT+Leucovorin vs. TS-1 as Adjuvant Treatment for Stage III Colon Cancer , and Investigate Predictive Factors Based on Gene Expression[NCT00660894] | Phase 3 | 1,535 participants (Actual) | Interventional | 2008-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
8 reviews available for oxonic acid and Cancer of Colon
| Article | Year |
|---|---|
Hypertriglyceridemia induced by S-1: A novel case report and review of the literature.
Topics: Acute Disease; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Combinations; Humans; Hypert | 2021 |
Applications of oral fluoropyrimidines in colon cancer: their role and new directions.
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Co | 2003 |
[A case of disseminated carcinomatosis of the bone marrow with disseminated intravascular coagulation caused by advanced colon cancer successfully treated with SOX/bevacizumab].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Bone | 2014 |
[A long-term survival case in advanced mucinous cystadenocarcinoma of the appendix using cytoreductive surgery and S-1/CDDP chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Appendix; Cisplatin; Colonic Neoplasms; Cystadenocar | 2011 |
[A case of peritoneal dissemination that exhibited a complete response to systemic chemotherapy following the resection of primary colon cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Colostomy; Combined Modality Ther | 2012 |
[Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Colonic Neoplasms; Docetaxe | 2003 |
[Adjuvant chemotherapy for colorectal cancer in Japan-current state and problem areas].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Colonic Neopla | 2007 |
[Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; | 2000 |
10 trials available for oxonic acid and Cancer of Colon
| Article | Year |
|---|---|
Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2020 |
A phase II study of combined chemotherapy with 5-week cycles of S-1 and CPT-11 plus bevacizumab in patients with metastatic colon cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Beva | 2013 |
S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2014 |
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer.
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplasti | 2015 |
A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2016 |
A phase I study of combination therapy with S-1 and irinotecan (CPT-11) in patients with advanced colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Col | 2009 |
[Efficacy and side effects of combination therapy of oxaliplatin and S-1 for colorectal cancer].
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Colo | 2011 |
Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2012 |
Optimal schedule of adjuvant chemotherapy with S-1 for stage III colon cancer: study protocol for a randomized controlled trial.
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Clinical Protocols; Colectomy; Colonic Neop | 2013 |
[Clinical evaluation of S-1, a new anticancer agent, in patients with advanced gastrointestinal cancer. S-1 Cooperative Gastrointestinal Study Group].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Administration Schedu | 1999 |
61 other studies available for oxonic acid and Cancer of Colon
| Article | Year |
|---|---|
Tegafur/gimeracil/oteracil (TS-1)-induced erythroderma with an extensive mucosal involvement and hand-foot syndrome.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neop | 2017 |
Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration.
Topics: Administration, Intravenous; Animals; CD11b Antigen; Cell Line, Tumor; Colonic Neoplasms; Drug Combi | 2017 |
Completely Responsive Multiple Liver Recurrence of Colon Cancer Treated Using Chemotherapy with Oral S-1 and Oxaliplatin Plus Bevacizumab : A Case Report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colonic Neoplasms; Drug Combinati | 2017 |
Pre-exposure to Fluorouracil Increased Trifluridine Incorporation and Enhanced its Anti-tumor Effect for Colorectal Cancer.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, | 2018 |
[A Case of Synchronous Liver Metastasis of Ascending Colon Cancer with Pathological Complete Response to S-1/Oxaliplatin (SOX) and Bevacizumab].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colon, Ascending; Colonic Neoplas | 2018 |
[A Case of Sister Mary Joseph's Nodule from Transverse Colon Cancer Effectively Treated with SOX plus Bevacizumab Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Colon, Transverse; Colo | 2018 |
[A case of metastatic colon cancer effectively treated by XELOX and IRIS].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colonic Neoplasms; | 2013 |
[A case of metastatic acsending colon cancer showing sustained complete response to chemotherapy with SOX and followed UFT].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; | 2013 |
A systemic analysis of S-1 regimens for treatment of patients with colon cancer.
Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Camptot | 2014 |
Adaptation of international guidelines for metastatic colorectal cancer: an asian consensus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2014 |
Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; Humans | 2015 |
Reply to the letter to the editor 'Is fluoropyrimidindes without oxaliplatin optimal for the adjuvant treatment of mainstream stage III colon cancer?' by Abali et al.
Topics: Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; Humans | 2015 |
Safety and pharmacokinetics of S-1 in a recurrent colon cancer patient with chronic myeloid leukemia treated with dasatinib: a case report.
Topics: Aged; Antimetabolites, Antineoplastic; Area Under Curve; Colonic Neoplasms; Dasatinib; Drug Combinat | 2014 |
[A case of liver and para-aortic lymph node metastasis of colorectal cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Colonic Neoplasms; Drug Combinations; Female; Humans; | 2015 |
[A case of surgery for stenosis of the colon from recurrent gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug Combinations; | 2014 |
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combin | 2014 |
[A Case of Adenosquamous Carcinoma of the Ascending Colon].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Chemotherapy, Adjuvant; Colectomy; | 2015 |
[A Successful Case of Treatment of Colonic Metastasis and Peritoneal Recurrence of Type 4 Gastric Cancer by Using Colectomy and Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colectomy; Colonic Neo | 2015 |
[Adjuvant Systemic Chemotherapy with S-1/Oxaliplatin or mFOLFOX6 after Curative Resection of Distant Metastases in Patients with Colorectal Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colonic Neoplasms; Dru | 2016 |
[A Case of Alternate-Day Treatment with S-1 in a Patient with Multiple Lung Metastases of Colon Cancer].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colonic Neoplasms; Drug | 2016 |
[Comparison of the Cost-Effectiveness of the SOX and COX Regimens in Patients with Unresectable Advanced and Recurrent Colorectal Cancer Using a Clinical Decision Analysis Approach].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colonic Neoplasms; Cost-Benefit | 2016 |
[A case of interstitial pneumonia induced by S-1/irinotecan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2008 |
[Three cases with liver metastasis from gastric or colon cancer successfully treated with S-1 combined with CPT- 11].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; | 2008 |
[A case of peritonitis carcinomatosa from goblet cell carcinoid of the appendix treated by intraperitoneal paclitaxel and systemic S-1 chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoid Tumor; Colonic Neoplasms; Colonoscop | 2008 |
[The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Dise | 2009 |
[Huge ascending colon carcinoma, treated successfully with S-1 plus CPT-11, followed by significant tumor reduction and curative resection--a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, | 2009 |
[A case of colon cancer with multiple liver metastases responding ot S-1 as third-line treatment following FOLFIRI and FOLFOX].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Camptothecin; Carcinoembryonic Antigen | 2010 |
[Long survival of a colon cancer case with synchronous multiple liver metastases responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplasms; Drug Combinations; Female; | 2010 |
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug C | 2010 |
Irinotecan overcomes the resistance to 5-fluorouracil in human colon cancer xenografts by down-regulation of intratumoral thymidylate synthase.
Topics: Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Blotting | 2010 |
[Pharmacokinetic study of S-1 for the treatment of peritoneal metastasis from colon cancer--using a mouse peritoneal metastasis model].
Topics: Administration, Oral; Animals; Cell Line, Tumor; Colonic Neoplasms; Disease Models, Animal; Drug Com | 2010 |
[Risk associated with severe hematological toxicity in patients with advanced or recurrent colonic cancer receiving combination chemotherapy of S-1 and irinotecan hydrochloride].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2010 |
[A case of advanced colon cancer with metastases to both supraclavicular and para-aortic lymph nodes effectively treated by radiation and S-1 therapy].
Topics: Administration, Oral; Colonic Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Human | 2010 |
[A case of drug-induced interstitial pneumonia caused by S-1 and CPT-11 combination therapy for advanced colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2011 |
[Pancreatoduodenectomy for locally advanced ascending colon cancer after neoadjuvant chemotherapy (mFOLFOX6)].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Colonic Neopl | 2011 |
[The feasibility of oral fluoropyrimidines as adjuvant chemotherapy after resection and local coagulation therapy of colorectal liver metastases].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemothe | 2011 |
Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancer drug.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Colonic Neopl | 2012 |
Abrogation of the accelerated blood clearance phenomenon by SOXL regimen: promise for clinical application.
Topics: Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Colonic Neoplas | 2013 |
[A case of advanced colon cancer with peritoneal dissemination completely responding to TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Colectomy; Colonic Neoplasms; | 2004 |
Esophageal cancer with colonic metastasis successfully treated by chemoradiotherapy followed by chemotherapy with S-1 and cisplatin.
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2004 |
[Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report].
Topics: Adenocarcinoma; Administration, Oral; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocol | 2005 |
[A case of transverse colon cancer with left supraclavicular lymph node metastasis and paraaortic lymph node metastases responding to TS-1].
Topics: Antimetabolites, Antineoplastic; Aorta; Biomarkers, Tumor; CA-19-9 Antigen; Clavicle; Colectomy; Col | 2005 |
[A case of peritoneal dissemination disappeared by CPT-11 + TS-1 combination chemotherapy].
Topics: Administration, Oral; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Ant | 2005 |
5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
Topics: Aged; Antimetabolites, Antineoplastic; beta-Alanine; Cardiovascular Diseases; Colonic Neoplasms; Dru | 2005 |
[A case of advanced colon cancer with metastases to both para-aortic lymph nodes and cervical vertebrae effectively treated by TS-1 therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta; Cecal Neoplasms; Cervical Vertebrae; C | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[Multiple hepatic metastases of colon cancer responding to combined therapy with TS-1 and CPT-11--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasm | 2006 |
[A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic | 2006 |
[Partial response of liver metastasis from colon cancer following intermittent oral administration of TS-1 after intra-hepatic arterial single injection of CDDP, doxorubicin and 5-FU].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2006 |
[Successful low-dose TS-1 administration in an elderly colon cancer patient with liver metastasis].
Topics: Adenocarcinoma; Aged, 80 and over; Antimetabolites, Antineoplastic; Appendiceal Neoplasms; Colonic N | 2007 |
[A case of ascending colon cancer with enlarged metastatic lymph nodes around superior mesenteric arterial root that responded dramatically to S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colon, Ascending; Colonic N | 2007 |
[An elderly case of recurrent colon cancer responding to weekly S-1 chemotherapy leading to partial response].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; | 2008 |
[Primary lung cancer that I was preoperative and needed discrimination for and one example of the repetition cancer of the colon].
Topics: Colonic Neoplasms; Colonoscopy; Drug Combinations; Female; Humans; Lung Neoplasms; Middle Aged; Neop | 2007 |
[A long survival case of advanced colon cancer with lung metastasis and cancerous pleuritis responding to CPT-11 and S-1 combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinat | 2008 |
[Multiple hepatic metastases and ovarian metastases of colon cancer responding to combined therapy with S-1 and CPT-11--a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonic Neoplasms; Drug Combinations; | 2008 |
Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts.
Topics: Angiogenesis Inhibitors; Animals; Capecitabine; Colonic Neoplasms; Deoxycytidine; Drug Combinations; | 2008 |
Complete response of transverse colon carcinoma to S1, a new chemotherapy agent: report of a case.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Colon; Colonic Neoplasms; Humans; Ma | 1995 |
Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell | 1996 |
Therapeutic effect of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) on liver metastasis of xenotransplanted human colon carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Colonic Neoplasms; Drug Combinations; Humans; Liver Neopla | 1999 |
[Combined effect of S-1 and CDDP as a modulator for colon 26 liver metastasis].
Topics: Animals; Antimetabolites, Antineoplastic; Body Weight; Cisplatin; Colonic Neoplasms; Drug Combinatio | 2000 |